- McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. BMJ 1967;1 (538): 451–455.
- Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy. Am J Emerg Med 1992;10 (2): 143–148.
- Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999;159 (6): 601–606.
- Magsino CH Jr, Ryan AJ Jr. Thyrotoxic periodic paralysis. South Med J 2000;93 (10): 996–1003.
- Mellgren G, Bleskestad HI, Aanderud S, Bindoff L. Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. Thyroid 2002;12 (1): 77–80.
- Tamai H, Tanaka K, Komaki G, Matsubayashi S, Hirota Y, Mori K, Kuma K, Kumagai LF, Nagataki S. HLA and thyrotoxic periodic paralysis in Japanese patients. J Clin Endocrinol Metab 1987;64 (5): 1075–1078.
- Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005;80 (1): 99–105.
- Gennari FJ. Hypokalemia. N Engl J Med 1998;339 (7): 451–458.
- Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 1991;303 (6810): 1096–1099.
- Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990;88 (6): 642–646.
- Ginsberg AM, Clutter WE, Shah SD, Cryer PE. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest 1981;67 (6): 1785–1791.
- Lee KO, Taylor EA, Oh VM, Cheah JS, Aw SE. Hyperinsulinemia in thyrotoxic hypokalemic periodic paralysis. Lancet 1991;337 (8749): 1063–1064.
- Edelman J, Stewart-Wynne EG. Respiratory and bulbar paralysis with relapsing hyperthyroidism. BMJ (Clin Res Ed) 1981;283 (6286): 275–276.
- Lin SH, Chiu JS, Hsu CW, Chau T. A simple and rapid approach to hypokalemic paralysis. Am J Emerg Med 2003;21 (6): 487–491.
- Lin YF, Wu CC, Pei D, Chu SJ, Lin SH. Diagnosing thyrotoxic periodic paralysis in the ED. Am J Emerg Med 2003;21 (4): 339–342.
- Ethier JH, Kamel KS, Magner PO, Lemann J Jr, Halperin ML. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis 1990;15 (4): 309–315.
- Boccalandro C, Lopez L, Boccalandro F, Lavis V. Electrocardiographic changes in thyrotoxic periodic paralysis. Am J Cardiol 2003;91 (6): 775–777.
- Hsu Y, Lin Y, Chau T, Liou JT, Kuo SW, Lin SH. Electrocardiographic manifestations in patients with thyrotoxic periodic paralysis. Am J Med Sci 2003;326 (3): 128–132.
- Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 2004;26 (2): 157–161.
- Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 2004;22 (7): 544–547.
- Yeung RT, Tse TF. Thyrotoxic periodic paralysis: effect of propranolol. Am J Med 1974;57 (4): 584–590.
- Shayne P, Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med 1994;24 (4): 736–740.
- Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 2000;18 (2): 199–202.
- Lin SH, Lin YF. Propanolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 2001;37 (3): 620–623.
- Huang TY, Lin SH. Thyrotoxic hypokalemic periodic paralysis reversed by propranolol without rebound hyperkalemia. Ann Emerg Med 2001;37 (4): 415–416.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 19, 2006 - Issue 2